Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis

Abstract Background In multiple sclerosis, coagulation factors have been shown to modulate inflammation. In this translational study, we investigated whether long-term anticoagulation with warfarin or rivaroxaban has beneficial effects on the course of autoimmune experimental encephalomyelitis (EAE)...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Leonie Stolz, Amin Derouiche, Kavi Devraj, Frank Weber, Robert Brunkhorst, Christian Foerch
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: BMC 2017-07-01
Sarja:Journal of Neuroinflammation
Aiheet:
Multiple sclerosis
Experimental autoimmune encephalomyelitis
Inflammation
Mice
Anticoagulation
Linkit:http://link.springer.com/article/10.1186/s12974-017-0926-2

Internet

http://link.springer.com/article/10.1186/s12974-017-0926-2

Samankaltaisia teoksia